Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.440
+0.010 (0.41%)
At close: Nov 20, 2024, 4:00 PM
2.360
-0.080 (-3.28%)
After-hours: Nov 20, 2024, 4:56 PM EST
Palisade Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 0.25 | - | - | - | - | |
| Gross Profit | - | 0.25 | - | - | - | - | |
| Selling, General & Admin | 6.06 | 6.2 | 8.76 | 9.31 | 6.2 | 7.27 | |
| Research & Development | 8.35 | 6.89 | 6.55 | 2.43 | 3.1 | 3.24 | |
| Operating Expenses | 14.41 | 13.1 | 15.31 | 11.74 | 9.3 | 10.51 | |
| Operating Income | -14.41 | -12.85 | -15.31 | -11.74 | -9.3 | -10.51 | |
| Interest Expense | -0.01 | -0.02 | -0.01 | -3.08 | -1.08 | -0.25 | |
| Interest & Investment Income | 0.7 | 0.7 | 0.2 | - | - | - | |
| Other Non Operating Income (Expenses) | -0.12 | 0.09 | 1.27 | 18.04 | 0.05 | 0.35 | |
| EBT Excluding Unusual Items | -13.84 | -12.08 | -13.85 | 3.22 | -10.32 | -10.41 | |
| Merger & Restructuring Charges | -0.23 | -0.23 | -0.41 | - | - | - | |
| Other Unusual Items | - | - | - | 0.28 | - | 0.36 | |
| Pretax Income | -14.07 | -12.3 | -14.26 | -26.62 | -10.32 | -10.05 | |
| Net Income | -14.07 | -12.3 | -14.26 | -26.62 | -10.32 | -10.05 | |
| Preferred Dividends & Other Adjustments | 0.02 | 0.02 | 0.29 | - | - | 0.01 | |
| Net Income to Common | -14.08 | -12.32 | -14.55 | -26.62 | -10.32 | -10.06 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | - | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | - | 0 | |
| Shares Change (YoY) | 210.81% | 677.03% | 370.85% | - | - | 99.30% | |
| EPS (Basic) | -13.66 | -27.01 | -247.89 | -2144.20 | - | -82.11 | |
| EPS (Diluted) | -13.66 | -27.01 | -247.95 | -2546.13 | - | -82.11 | |
| Free Cash Flow | -12.56 | -11.14 | -13.37 | -14.77 | -4.77 | -6.76 | |
| Free Cash Flow Per Share | -12.18 | -24.42 | -227.82 | -1185.25 | - | -55.15 | |
| Gross Margin | - | 100.00% | - | - | - | - | |
| Operating Margin | - | -5138.00% | - | - | - | - | |
| Profit Margin | - | -4926.40% | - | - | - | - | |
| Free Cash Flow Margin | - | -4454.80% | - | - | - | - | |
| EBITDA | -14.4 | -12.84 | -15.31 | -11.74 | -9.29 | -10.51 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -14.41 | -12.85 | -15.31 | -11.74 | -9.3 | -10.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.